Morning Briefing
Summaries of health policy coverage from major news organizations
Glaxo To Pay $750 Million Settlement For Defective, Unsafe Medicines
Drugmaker GlaxoSmithKline has agreed to pay $750 million to settle civil and criminal charges that the company for years knowingly sold 20 defective or dangerous drugs manufactured at a contaminated plant.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
